BCL2 and Hepatic fibrosis: Preconditioning of MSCs with MT showed lower expressions of TGF-β1 and Bax and lowered ALT content but higher expressions of MMPs and Bcl2 with the MSCs group in the treatment of liver fibrosis (105).